Granted Patent
B2
US 12,716,845 · App. 17/146,301 · Granted Aug 25, 2026
Methods of disease detection and characterization using computational analysis of urine raman spectra
View Patent ↗
Loading inventors, assignments & file history…
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 5, 2021
From: ROBERTSON, JOHN L.; SENGER, RYAN
To: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
Reel/Frame 055816/0700 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 5, 2021
From: VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY
To: VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.
Reel/Frame 055816/0823 →
Continuity (5)
Provisional Application
62993908
· Mar 24, 2020
Provisional Application
62983045
· Feb 28, 2020
Provisional Application
62958993
· Jan 9, 2020
Provisional Application
62958983
· Jan 9, 2020
References Cited (222)
US 3598727A
· Willock
· 1971
[cited by applicant]
US 4172033A
· Willock
· 1979
[cited by applicant]
US 4267040A
· Schal
· 1981
[cited by applicant]
US 4769134A
· Allan et al.
· 1988
[cited by applicant]
US 5112127A
· Carrabba et al.
· 1992
[cited by applicant]
US 5507723A
· Keshaviah
· 1996
[cited by applicant]
US 5534997A
· Schrader
· 1996
[cited by applicant]
US 5553616A
· Ham et al.
· 1996
[cited by applicant]
US 5786893A
· Fink et al.
· 1998
[cited by applicant]
US 6100975A
· Smith et al.
· 2000
[cited by applicant]
US 6151522A
· Alfano et al.
· 2000
[cited by applicant]
US 6284131B1
· Hogard et al.
· 2001
[cited by applicant]
US 6632680B1
· Deslauriers et al.
· 2003
[cited by applicant]
US 7326576B2
· Womble et al.
· 2008
[cited by applicant]
US 7505128B2
· Zribi et al.
· 2009
[cited by applicant]
US 7524671B2
· Clarke et al.
· 2009
[cited by applicant]
US 7651851B2
· Clarke et al.
· 2010
[cited by applicant]
US 8125623B2
· Munger et al.
· 2012
[cited by applicant]
US 8133194B2
· Szamosfalvi et al.
· 2012
[cited by applicant]
US 8638431B2
· Ashok et al.
· 2014
[cited by applicant]
US 8699020B1
· Zhou et al.
· 2014
[cited by applicant]
US 8945936B2
· Ash et al.
· 2015
[cited by applicant]
US 8953159B2
· Cunningham et al.
· 2015
[cited by applicant]
US 9089126B2
· Faulkner et al.
· 2015
[cited by applicant]
US 9215985B2
· Gross et al.
· 2015
[cited by applicant]
US 9267845B2
· Ichijyo et al.
· 2016
[cited by applicant]
US 9550020B2
· Kelly et al.
· 2017
[cited by applicant]
US 9713666B2
· Pudil et al.
· 2017
[cited by applicant]
US 20060281068A1
· Maier et al.
· 2006
[cited by applicant]
US 20080158544A1
· Womble et al.
· 2008
[cited by applicant]
US 20100165324A1
· Womble et al.
· 2010
[cited by applicant]
US 20120008130A9
· Munger et al.
· 2012
[cited by applicant]
US 20120099102A1
· Bello
· 2012
[cited by applicant]
US 20140052386A1
· Guenther et al.
· 2014
[cited by applicant]
US 20160252459A1
· Bell et al.
· 2016
[cited by applicant]
US 20210270742A1
· Senger et al.
· 2021
[cited by applicant]
US 20230147592A1
· Robertson et al.
· 2023
[cited by applicant]
EP 1637586A2
· 2006
[cited by applicant]
WO 2007011571A2
· 2007
[cited by applicant]
WO 2012140022A1
· 2012
[cited by applicant]
WO 2015164620A1
· 2015
[cited by applicant]
WO 2016004322A2
· 2016
[cited by applicant]
WO 2020176663A1
· 2020
[cited by applicant]
Fisher, A. K. (2018). Raman Chemometrics and Application to Enzyme Kinetics and Urinalysis [Doctoral dissertation, Virginia Tech]. Semantic Scholar. 142 p. <URL: www.semanticscholar.org/paper/Raman-Chemometrics-and-Appl…
[cited by examiner]
Del Mistro et al., (2015). Analytical and Bioanalytical Chemistry, 407, 3271-3275. (Year: 2015).
[cited by examiner]
Bispo et al., (2013). Journal of biomedical optics, 18(8), p. 087004-087004. (Year: 2013).
[cited by examiner]
Xu and Du, (Jul. 27-Aug. 1, 2019). ISREA:A Novel Approach for Raman Spectrum Baseline Correction and Its Application on Real Data [abstract]. JSM 2019, Denver, CO. [Retrieved online Jun. 2, 2023] <URL: https://ww2.amsta…
[cited by examiner]
Fisher et al., (2018). The Rametrix™ Lite Toolbox v1.0 for MATLAB®. Journal of Raman Spectroscopy, 49(5), 885-896. (Year: 2018).
[cited by examiner]
Liu et al., ((2015). Goldindec: a novel algorithm for Raman spectrum baseline correction. Applied spectroscopy, 69(7), 834-842).
[cited by examiner]
Xu et al., (2021). ISREA: an efficient peak-preserving baseline correction algorithm for Raman spectra. Applied Spectroscopy, 75(1), 34-45.
[cited by examiner]
Schena, F.P., 2011. Management of patients with chronic kidney disease. Internal and emergency medicine, 6, pp. 77-83. (Year: 2011).
[cited by examiner]
Bonifacio, A., Cervo, S. and Sergo, V., 2015. Label-free surface-enhanced Raman spectroscopy of biofluids: fundamental aspects and diagnostic applications. Analytical and bioanalytical chemistry, 407, pp. 8265-8277. (Ye…
[cited by examiner]
Webster, A.C., Nagler, E.V., Morton, R.L. and Masson, P., 2017. Chronic kidney disease. The lancet, 389(10075), pp. 1238-1252. (Year: 2017).
[cited by examiner]
Van Rhijn, B.W., Van der Poel, H.G. and van Der Kwast, T.H., 2005. Urine markers for bladder cancer surveillance: a systematic review. European urology, 47(6), pp. 736-748. (Year: 2005).
[cited by examiner]
Canetta, E., et al., 2011. Modulated Raman spectroscopy for enhanced identification of bladder tumor cells in urine samples. Journal of biomedical optics, 16(3), pp. 037002/1-037002/7 (7 pages). (Year: 2011).
[cited by examiner]
Movasaghi, Z., Rehman, S. and Rehman, I.U., 2007. Raman spectroscopy of biological tissues. Applied Spectroscopy Reviews, 42(5), pp. 493-541. (Year: 2007).
[cited by examiner]
Hassler, L. et al., “Evidence for and against direct kidney infection by SARS-CoV-2 in patients with COVID-19”, CJASN 2021; 16, 1755-1765, 2021.
[cited by applicant]
Hirsch, J. S. et al., “Acute kidney injury in patients hospitalized with COVID-19”, Kidney Int. 2020; 98: 209-218.
[cited by applicant]
Huttanus, H. et al. “Raman Chemometric Urinalysis (Rametrix™) as a screen for bladder cancer,” PLoS One. 2020; 15(8): e0237070. Published online Aug. 21, 2020.
[cited by applicant]
Hyde, F.W. et al., “Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease,” J Clin Microbiol 27, 58-61 (1989).
[cited by applicant]
Jha, V. et al., “Chronic kidney disease: global dimension and perspectives”, The Lancet, 2013, 382(9888), 260-272.
[cited by applicant]
Kerr, L.T. et al., Methodologies for bladder cancer detection with Raman based urine cytology. Analytical Methods, 2016;8: 4991-5000, Abstract only.
[cited by applicant]
Lafuente, B. et al.,“The power of databases: the RRUFF project”. In: T. Armbruster, R.M. Danisi, editors. Highlights in Mineralogical Crystallography. W. De Gruyter, Berlin, Germany, 2015, 32 pages.
[cited by applicant]
Lee, S. et al., “Improving Clearance for Renal Replacement Therapy”, Kidney 360 Publish Ahead of Print, published May 12, 2021, 32 pages.
[cited by applicant]
Lo, P.A. et al., Automatic Raman spectroscopic urine crystal identification system using fluorescent image-guided 2D scanning platform with Fe3O4 crystal violet nanoclusters. J Raman Spectrosc 2018;50(1)34-50, Abstract …
[cited by applicant]
Magni, R. et al., “Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl terminus domain in early stage Lyme borreliosis,” J Transl Med (2015) 13: 346, 22 pages.
[cited by applicant]
Meyer, T. W. et al., “Dialysis Cannot be Dosed”, Semin Dial. 2011; 24(5): 471-479, 19 pages.
[cited by applicant]
Minka “A statistical learning/pattern recognition glossary.” Retrieved Jun. 29, 2005: 2008. Available online http://alumni.media.mit.edu/~tpminka/statlearn/glossary/glossary.htm., accessed Jul. 1, 2020 (Year: 2005).
[cited by applicant]
Mohamed, M. M. et al., “Acute kidney injury associated with coronavirus disease 2019 in urban New Orleans”, Kidney360 2020; 1: 614-622, 19 pages.
[cited by applicant]
Moledina, D. G. et al., “The association of COVID-19 with acute kidney injury independent of severity of illness: A multicenter cohort study”, Am. J. Kidney Dis. 2021; 77: 490-499.e1, 12 pages.
[cited by applicant]
Movasaghi, Z. et al., Raman Spectroscopy of Biological Tissues. Appl Spectrosc Rev. 2007;42: 493-541.
[cited by applicant]
Murugan, R. and Kellum, J. A., “Acute kidney injury: what's the prognosis?” Nat. Rev. Nephrol. 2011; 7(4): 209-217.
[cited by applicant]
Ng, J. H. et al., “Pathophysiology and pathology of acute kidney injury in patients with COVID-19”, Adv. Chronic Kidney Dis. 2020; 27: 365-376.
[cited by applicant]
Pegalajar-Jurado, A. et al., (2018) “Identification of urine metabolites as biomarkers of early Lyme Disease,” Nature Scientific Reports 8:12204, 12 pages.
[cited by applicant]
Pei, G. et al., “Renal involvement and early prognosis in patients with COVID-19 pneumonia”, J. Am. Soc. Nephrol. 2020; 31: 1157-1165.
[cited by applicant]
Rauter, C. et al., “Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis,” Clin Diagn Lab Immunol 12: 910-917 (2005).
[cited by applicant]
Richardson, S. et al., “Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area”, JAMA 2020; 323: 2052-2059.
[cited by applicant]
Robertson, J. L. et al. (2022), “Alterations in the molecular composition of COVID-19 patient urine, detected using Raman spectroscopic/computational analysis”, Plos One 17(7): e0270914, 16 pages.
[cited by applicant]
Senger, R.S. and Robertson, J.L. “The RametrixTM PRO Toolbox v1.0 for MATLAB®”. PeerJ. 2020. 8: e8179.
[cited by applicant]
Senger, R.S. and Scherr, D., “Resolving complex phenotypes with Raman spectroscopy and chemometrics”, Curr. Opin. Biotechnol. 2020; 66:277-282, 16 pages.
[cited by applicant]
Senger, R.S. et al. “Spectral characteristics of urine from patients with end-stage kidney disease analyzed using Raman Chemometric Urinalysis (Rametrix)”. PLoS One. 2020. 15(1): e0227281).
[cited by applicant]
Senger, R.S. et al. “Spectral characteristics of urine specimens from healthy human volunteers analyzed using Raman chemometric urinalysis (Rametrix)”. PLoS One. 2019. 14(9): e0222115.
[cited by applicant]
Shapiro, A. et al., Raman molecular imaging: a novel spectroscopic technique for diagnosis of bladder cancer in urine specimens. Eur Urol. 2011;59: 106-112.
[cited by applicant]
Sharma, P. et al., “COVID-19-associated kidney injury: A case series of kidney biopsy findings”, J. Am. Soc. Nephrol. 2020; 31: 1948-1958.
[cited by applicant]
Shen, Y. et al., “Raman imaging of small biomolecules”, Annu. Rev. Biophys. 2019; 48:347-369.
[cited by applicant]
Shinzawa, H. et al., “Multivariate data analysis for Raman spectroscopic imaging” Journal of Raman Spectroscopy, 2009, 40:1720-1725.
[cited by applicant]
Stemcell Technologies, “Loading the RoboSepTM-S Carousel and Starting a Run”, 2017, https://www.youtube.com/watch?v=uhMR_xheVik.
[cited by applicant]
Su, H. et al., “Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China”, Kidney Int. 2020; 98: 219-227.
[cited by applicant]
Thermo Fisher Scientific, “DXR SmartRaman Spectrometer”, 2017, 8 pages.
[cited by applicant]
Turi, K. N. et al., “A review of metabolomics approaches and their application in identifying casual pathways of childhood asthma”, J. Allergy Clin. Immunol. 2018; 141(4):1191-1201, 48 pages.
[cited by applicant]
Ward, R. A. et al., “Dialysate Flow Rate and Delivered Kt/Vurea for Dialyzers with Enhanced Dialysate Flow Distribution”, Clin J Am Soc Nephrol 6: 2235-2239, Sep. 2011.
[cited by applicant]
Xu, Y. et al., “Sparse logistic regression on functional data”, Stat. Interface, vol. 0 (2021) 1, 9 pages.
[cited by applicant]
Yang, Y.T. et al., Off-Resonance SERS Nanoprobe-Targeted Screen of Biomarkers for Antigens Recognition of Bladder Normal and Aggressive Cancer Cells. Analytical Chemistry 2019;91(13): 8213-8220.
[cited by applicant]
Zu, T.N.K. et al., Assessment of ex vivo Perfused Liver Health by Raman Spectroscopy. J Raman Spectrosc. 2015; 46: 551-558, Abstract only.
[cited by applicant]
Zu, T.N.K. et al., Near-Real-Time Analysis of the Phenotypic Responses of
[cited by applicant]
(Robertson, John L. et al.) Co-pending U.S. Appl. No. 15/305,940, filed Oct. 21, 2016, Specification, Claims, and Figures.
[cited by applicant]
(Robertson, John L. et al.) Co-pending U.S. Appl. No. 17/345,735, filed Jun. 11, 2021, Specification, Claims, and Figures.
[cited by applicant]
(Robertson, John L. et al.) Co-pending U.S. Appl. No. 17/434,294, filed Aug. 26, 2021, Specification, Claims, and Figures.
[cited by applicant]
(Robertson, John L. et al.) Co-Pending U.S. Appl. No. 17/982,019, filed Nov. 7, 2022, Specification, Drawings, and Claims.
[cited by applicant]
(Senger, R. et al.) Co-Pending U.S. Appl. No. 17/188,737, filed Mar. 1, 2021, Specification, Drawings, and Claims.
[cited by applicant]
AcuTech Scientific Inc., “The World Highest Reproducible Raman Spectrometer: AcuScan 1500 Manual(2:22)”, 2014, https://youtu.be/43iwhIGSZOA?si=dqAIVKAUv1xQ3cVm.
[cited by applicant]
Athamneh, A.I.M. and Senger R.S. Peptide-Guided Surface-Enhanced Raman Scattering Probes for Localized Cell Composition Analysis. Appl Env Microbiol. 2012;78: 7805-7808.
[cited by applicant]
Athamneh, A.I.M. et al., Phenotypic Profiling of Antibiotic Response Signatures in
[cited by applicant]
Balan et al. “Vibrational spectroscopy fingerprinting in medicine: from molecular to clinical practice.” Materials 12.18 (2019): 2884, 40 pages.
[cited by applicant]
Batlle, D. et al. “Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology”, J. Am. Soc. Nephrol. 2020; 31: 1380-1383.
[cited by applicant]
Beattie, J. Renwick et al. “Prediction of Adipose Tissue Composition Using Raman Spectroscopy: Average Properties and Individual Fatty Acids”, 2006, 8 pages.
[cited by applicant]
Bird, B. et al., Cytology by Infrared Micro-Spectroscopy: Automatic Distinction of Cell Types in Urinary Cytology. Vib Spectrosc. 2008;48: 101-106, 15 pages.
[cited by applicant]
Bouatra, S. et al. The Human Urine Metabolome. Plos One. 2013;8: e73076, 25 pages.
[cited by applicant]
Canetta, E. et al., Modulated Raman spectroscopy for enhanced identification of bladder tumor cells in urine samples. J Biomed Opt. 2011;16(3): 037002, 8 pages.
[cited by applicant]
Castelli, F. A. et al., “Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests”, Anal. Bioanal. Chem. 414, 759-789 (2022).
[cited by applicant]
Chen, Y. T. et al., “Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: A systematic review and meta-analysis”, Crit. Care 2020; 24: 439, 4 pages.
[cited by applicant]
Chen, Z. and Kim, J. “Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases”, BMC Urol. 2016; 16 (Mar. 22): 11, 13 pages.
[cited by applicant]
Cheng, S. et al., “Potential impact and study considerations of metabolomics in cardiovascular health and disease: A scientific statement from the American Heart Association”, Circ. Cardiobasc. Genet. 2017; 10(2): e0000…
[cited by applicant]
Cheng, Y. et al., “Kidney disease is associated with in-hospital death of patients with COVID-19”, Kidney Int. 2020; 97: 829-838.
[cited by applicant]
Chiu, Y.C. et al., Enhanced Raman sensitivity and magnetic separation for urolithiasis detection using phosphonic acid-terminated Fe3O4 nanoclusters. J. Mater. Chem. B 2015(3):4282-4290.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Applicant-Initiated Interview Summary dated Mar. 28, 2022, 3 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Applicant-Initiated Interview Summary, dated Jan. 18, 2023, 4 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Final Office Action dated Dec. 1, 2021, 27 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Final Office Action dated Dec. 22, 2022, 18 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Final Office Action dated Jul. 13, 2020, 22 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Non-Final Office Action dated Jun. 2, 2022, 37 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Non-Final Office Action dated May 7, 2021, 24 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Non-Final Office Action dated Nov. 1, 2019, 16 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Notice of Allowance dated Feb. 1, 2023, 7 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Response After Final Office Action, dated Jan. 13, 2023, 6 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Response to Dec. 1, 2021 Final Office Action, dated Feb. 25, 2022, 17 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Response to Jul. 13, 2020 Final Office Action, filed Oct. 13, 2020, 11 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Response to Jun. 2, 2022 Non-Final Office Action, dated Dec. 2, 2022, 31 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Response to Mar. 27, 2019 Restriction Requirement, filed Sep. 27, 2019, 9 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Response to May 7, 2021 Non-Final Office Action, filed Sep. 7, 2021, 14 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Response to Nov. 1, 2019 Non-Final Office Action, filed May 1, 2020, 13 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Restriction Requirement dated Mar. 27, 2019, 9 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 15/305,940, Rule 132 Affidavit dated Dec. 2, 2022, 23 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 17/345,735, Non-Final Office Action dated Jun. 14, 2023, 15 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 17/345,735, Notice of Allowance dated Dec. 1, 2023, 7 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 17/345,735, Response to Jun. 14, 2023 Non-Final Office Action, dated Nov. 14, 2023, 8 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 17/434,294, Notice of Allowance dated Dec. 29, 2021, 11 pages.
[cited by applicant]
Co-pending International Application No. PCT/US20/19964, International Search Report and Written Opinion dated May 22, 2020, 7 pages.
[cited by applicant]
Dator, R. et al., “Metabolomics profiles of smokers from two ethnic groups with differing lung cancer risk”, Chem. Res. Toxicol. 2020; 33(8):2087-2098.
[cited by applicant]
Daugirdas, John T. et al. “Improved equation for estimating single-pool Kt/V at higher dialysis frequencies”, Nephrol Dial Transplant (2013) 28: 2156-2160.
[cited by applicant]
Daugirdas, John T. et al. “Surface-Area-Normalized Kt/V: A Method of Rescaling Dialysis Dose to Body Surface Area-Implications for Different-Size Patients by Gender”, Semin Dial. 2008; 21(5): 415-421, 17 pages.
[cited by applicant]
Emwas, A. H. et al., “Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review”, Metabolomics 2015; 11(4): 872-894.
[cited by applicant]
Fisher, M. et al., “AKI in hospitalized patients with and without COVID-19: A comparison study”, J. Am. Soc. Nephrol. 2020; 31: 2145-2157.
[cited by applicant]
Gautam, R. et al. “Review of multidimensional data processing approaches for Raman and infrared spectroscopy”. EPJ Techn. Instrum. 2015. 2(1): 8, 38 pages.
[cited by applicant]
Gowda, G. A. et al., “Metabolomics-based methods for early disease diagnostics”, Expert Rev. Mol. Diagn. 2008; 8(5):617-633, 28 pages.
[cited by applicant]
(Robertson, John L. et al) Co-pending International Application No. PCT/US20/19964, filed Feb. 26, 2020, Specification, Claims, Figures.
[cited by applicant]
(Robertson, John L. et al.) Co-pending U.S. Appl. No. 18/122,180, filed Mar. 16, 2023, Specification, Claims, and Figures.
[cited by applicant]
(Robertson, John L. et al.) Co-Pending International Application No. PCT/US2015/027323, filed Apr. 23, 2015 and published as WO2015164620 on Oct. 29, 2015, Specification, Claims, Figures.
[cited by applicant]
Afseth, N.K. and Kohler, A. “Extended multiplicative signal correction in vibrational spectroscopy, a tutorial” Chemometrics and Intelligent Laboratory Systems. 2012. 117: 92-99. 10.1016/j.chemolab.2012.03.004, Abstract…
[cited by applicant]
Beattie, J.R. and McGarvey, J.J. “Estimation of signal backgrounds on multivariate loadings improves model generation in face of complex variation in backgrounds and constituents”. J of Raman Spectrosc. 2013. 44(2): 329…
[cited by applicant]
Boelens, H.F.M & Eilers, P.H.C., Baseline correction with asymmetric least squares smoothing, Leiden University Medical Centre report (2005).
[cited by applicant]
Cai, T.T. et al. “Enhanced Chemical Classification of Raman Images Using Multiresolution Wavelet Transformation”. Appl. Spectrosc. 2001. 55(9): 1124-1130.
[cited by applicant]
Cai, Y. et al. “Baseline correction for Raman spectra using penalized spline smoothing based on vector transformation”. Anal. Methods. 2018. 10(28): 3525-3533, Abstract only.
[cited by applicant]
Candeloro, P. et al. “Raman database of amino acids solutions: A critical study of extended multiplicative signal correction”. Analyst. 2013. 138(24): 7331-7340).
[cited by applicant]
Carswell, W. et al., “Raman Spectroscopy as a non-cytological detection and quantification urinalysis method for microhematuria in human urine”, Appl. Spectro. 2022. 76(3): 1-11.
[cited by applicant]
Celia-May, D. et al. Theoretical principles of Raman spectroscopy. Phys. Sci. Rev.:2019; 19:4.
[cited by applicant]
Centers for Disease Control and Prevention, National Chronic Kidney Disease Factsheet, 2014, 4 pages.
[cited by applicant]
Chen, D. et al. “Adaptive wavelet transform suppresses background and noise for quantitative analysis by Raman spectrometry”. Anal. Bioanal. Chem. 2011. 400(2): 625-634, Abstract Only.
[cited by applicant]
Collins, AJ et al., “Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%,” J Am Soc Nephrol 12(11):2465-73, 2001.
[cited by applicant]
Co-pending U.S. Appl. No. 18/122,180, Non-Final Office Action dated May 24, 2024, 20 pages.
[cited by applicant]
Co-pending international Application No. PCT/US2015/027323 International Search Report and Written Opinion dated Sep. 8, 2015, 11 pages.
[cited by applicant]
Das, R.S. and Agrawal, Y.K. “Raman spectroscopy: Recent advancements, techniques and applications”. Vib. Spectrosc. 2011. 57(2): 163-176, Abstract only.
[cited by applicant]
Depciuch, J. et al. “Application of Raman Spectroscopy and Infrared Spectroscopy in the Identification of Breast Cancer”. Appl. Spectrosc. 2016. 70(2): 251-263.
[cited by applicant]
Dobre, M, Meyer, TW, Hostetter, TH, “Searching for uremic toxins,” Clin J Am Soc Nephrol 8: 322-327, 2013.
[cited by applicant]
Duranton, F et al., “Normal and pathological concentrations of uremic toxins,” J Am Soc Nephrol 23: 1258-1270, 2012.
[cited by applicant]
Eilers, P.H.C. “A perfect smoother”. Anal. Chem. 2003. 75(14): 3631-3636, Abstract only.
[cited by applicant]
Eknoyan, G. et al., “Effects of dialysis dose and membrane flux in maintenance hemodialysis,” New Engl Journ Med 347: 2010-2019, 2002.
[cited by applicant]
He, S. et al. “Baseline correction for Raman spectra using an improved asymmetric least squares method”. Anal. Methods. The Royal Society of Chemistry, 2014. 6(12): 4402-4407.
[cited by applicant]
Ito, S, Yoshida, M, “Review: Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients,” Toxins 6: 665-678, 2014; doi:10.3390/toxins6020665.
[cited by applicant]
Kim, Jaejin et al., “Feasibility Study for the Monitoring of Urea in Dialysate Solution using Raman Spectroscopy”, Bull. Korean Chem. Soc. 2011, vol. 32, No. 3 805-808.
[cited by applicant]
Layman-Amato, R. et al., “Water treatment for hemodialysis: an update”, Nephrology Nursing J., 2013, 40(5), 383-404, 465.
[cited by applicant]
Levey, AS et al., “Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we need to learn? Where do we go from here?,” Amer J Kid Disease 32: 853-906, 1998.
[cited by applicant]
Li, J. et al. “Wavelet transform based on the optimal wavelet pairs for tunable diode laser absorption spectroscopy signal processing”. Appl. Spectrosc. 2015. 69(4): 496-506.
[cited by applicant]
Liabeuf, S, Drukke, TB, Massay, ZA, “Protein-bound uremic toxins: new insight from clinical studies,” Toxins 3: 911-919, 2011.
[cited by applicant]
Lieber, C.A. and Mahadevan-Jansen, A. “Automated Method for Subtraction of Fluorescence from Biological Raman Spectra”. Appl. Spectrosc. 2003. 57: 1363-1367, Abstract only.
[cited by applicant]
Liland, K. et al. “Model-based pre-processing in Raman spectroscopy of biological samples”. J. Raman Spectrosc. 2016. 47(6): 643-650.
[cited by applicant]
Liland, K. et al. “Optimal Choice of Baseline Correction for Multivariate Calibration of Spectra” Appl. Spectrosc. 2010, 64: 1007-1016.
[cited by applicant]
Mahadevan-Jansen, A. and Richards-Kortum, R.R. “Raman spectroscopy for the detection of cancers and precancers”. J. Biomed. Opt. 1996. 1(1): 31-70.
[cited by applicant]
Martens, H. and Stark, E. “Extended multiplicative signal correction and spectral interference subtraction: new preprocessing methods for near infrared spectroscopy.” J. Pharm. Biomed. Anal. 1991. 9 8: 625-635, Abstract…
[cited by applicant]
Mazet, V. et al. “Background removal from spectra by designing and minimising a non-quadratic cost function”. Chemom. Intell. Lab. Syst. 2005. 76(2): 121-133.
[cited by applicant]
Meyer, TW, Hostetter, TH, “Uremia”, New Engl J Med 357: 1316-1325, 2007.
[cited by applicant]
Mosier-Boss, P.A. et al. “Fluorescence rejection in Raman spectroscopy by shifted-spectra, edge detection, and FFT filtering techniques”. Appl. Spectrosc. 1995. 49: 630-638.
[cited by applicant]
Peng, J. et al. “Asymmetric least squares for multiple spectra baseline correction”. Anal. Chim. Acta. 2010. 683(1): 63-68.
[cited by applicant]
Scholtes-Timmerman, M. et al. “A novel approach to correct variations in Raman spectra due to photo-bleachable cellular components”. Analyst. 2009. 134(2): 387-393.
[cited by applicant]
Schulze, G. et al. “Investigation of selected baseline removal techniques as candidates for automated implementation”. Appl. Spectrosc. 2005. 59(5): 545-574.
[cited by applicant]
Senger, R.S., Kavuru, V., Sullivan, M., Gouldin, A., Lundgren, S., Merrifield, K. (2019), Spectral characteristics of urine specimens from healthy human volunteers analyzed using Raman chemometric urinalysis (Rametrix).…
[cited by applicant]
Senger, R.S., Sullivan, M., Gouldin, A., Lundgren, S., Merrifield, K., Steen, C., Spectral characteristics of urine from patients with end-stage kidney disease analyzed using Raman Chemometric Urinalysis (Rametrix) PLoS…
[cited by applicant]
Shusterman, V. et al. “Enhancing the precision of ECG baseline correction: selective filtering and removal of residual error”. Comput. Biomed. Res. 2000. 33(2): 144-160, Abstract only.
[cited by applicant]
Stellman, C.M. et al. “Multivariate Raman Imaging of Simulated and Real World Glass-Reinforced Composites”. Appl. Spectrosc. 1996. 50: 552-557, Abstract only.
[cited by applicant]
Talari, A. et al. Raman spectroscopy of biological tissues. Appl. Spectrosc. Rev. 2015; 50(1): 46-111.
[cited by applicant]
Vanholder, R, et al., European Uremic Toxin Work Group (EUTox), “Review on uremic toxins: classification, concentration, and interindividual variability,” Kidney Int. May 2003;63(5):1934-43, 2003.
[cited by applicant]
Wang, N. et al. “Recent advances in spontaneous Raman spectroscopic imaging: Instrumentation and applications” Current Medicinal Chemistry, vol. 27, No. 36, 2020, pp. 6188-6207(20), Available online Jul. 26, 2019, Abstr…
[cited by applicant]
Zhang, D. and Ben-Amotz, D. “Enhanced Chemical Classification of Raman Images in the Presence of Strong Fluorescence Interference”. Appl. Spectrosc. OSA, 2000, 54(9): 1379-1383, Abstract only.
[cited by applicant]
Zhao, J. et al. “Automated autofluorescence background subtraction algorithm for biomedical Raman spectroscopy”. Appl. Spectrosc. 2007. 61(11): 1225-1232, Abstract only.
[cited by applicant]
Cai, Y. et al. “Baseline correction for Raman spectra using penalized spline smoothing based on vector transformation”. Anal. Methods. 2018. 10(28): 3525-3533.
[cited by applicant]
Co-Pending U.S. Appl. No. 17/188,737, Non-Final Office Action dated Mar. 24, 2025, 32 pages.
[cited by applicant]
Co-Pending U.S. Appl. No. 17/188,737, Response to Dec. 23, 2024 Restriction Requirement, dated Feb. 15, 2025, 2 pages.
[cited by applicant]
Co-Pending U.S. Appl. No. 17/188,737, Restriction Requirement dated Dec. 23, 2024, 7 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 18/122,180, Corrected Notice of Allowance dated May 23, 2025, 5 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 18/122,180, Examiner Interview Summary dated Sep. 19, 2024, 7 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 18/122,180, Final Office Action dated Oct. 29, 2024, 16 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 18/122,180, Notice of Allowance dated May 12, 2025, 7 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 18/122,180, Response to May 24, 2024 Non-Final Office Action, dated Sep. 24, 2024, 7 pages.
[cited by applicant]
Co-pending U.S. Appl. No. 18/122,180, Response to Oct. 29, 2024 Final Office Action, dated Jan. 29, 2025, 7 pages.
[cited by applicant]
Jensen, P. S. et al., “Online monitoring of urea concentration in dialysate with dual-beam Fourier-transform near-infrared spectroscopy”, Journal of Biomedical Optics 9(3), 553-557 (May/Jun. 2004).
[cited by applicant]
Collins et al., “The State of Chronic Kidney Disease, ESRD, and Morbidity and Mortality in the First Year of Dialysis,” 2009, Clin. J. Am. Soc. Nephrol., 4, p. S5-S11.
[cited by applicant]
Co-Pending U.S. Appl. No. 17/188,737, Final Office Action dated Oct. 29, 2025, 37 pages.
[cited by applicant]
Co-Pending U.S. Appl. No. 17/188,737, Response to Mar. 24, 2025 Non-Final Office Action dated Sep. 24, 2025, 35 pages.
[cited by applicant]